Regulation (EU) 2024/2076
For the purpose of this Annex (Part-MED), the following definitions shall apply:
â âlimitationâ means a condition placed on the medical certificate or cabin crew medical report that shall be complied with whilst exercising the privileges of the licence or cabin crew attestation;
â âaero-medical examinationâ means an inspection, palpation, percussion, auscultation or any other means of investigation for determining the medical fitness to exercise the privileges of the licence, or to carry out cabin crew safety duties;
â âaero-medical assessmentâ means the conclusion on the medical fitness of an applicant based on the evaluation of the applicant as required in this Annex (Part-MED) and further examinations and medical tests as clinically indicated;
â âsignificantâ means a degree of a medical condition, the effect of which would prevent the safe exercise of the privileges of the licence or of the cabin crew safety duties;
â âapplicantâ means a person applying for, or being the holder of, a medical certificate who undergoes an aero-medical assessment of fitness to exercise the privileges of the licence, or to carry out cabin crew safety duties;
â âmedical historyâ means a narrative or record of past diseases, injuries, treatments or other medical facts, including unfit assessment(s) or limitation of a medical certificate, that are or may be relevant to an applicantâs current state of health and aero-medical fitness;
â âlicensing authorityâ means the competent authority of the Member State that issued the licence, or to which a person applies for the issuance of a licence, or, when a person has not yet applied for a licence, the competent authority as determined in accordance with FCL.001 of Annex I (Part-FCL);
â âcolour safeâ means the ability of an applicant to readily distinguish the colours used in air navigation and to correctly identify aviation coloured lights;
â âhelicopter emergency medical services (HEMS) operationâ means a âHEMS flightâ as defined in point 61 of Annex I to Regulation (EU) No 965/2012;
â âinvestigationâ means the assessment of a suspected pathological condition of an applicant by means of examinations and tests in order to verify the presence or absence of a medical condition;
â âaccredited medical conclusionâ means the conclusion reached by one or more medical experts acceptable to the licensing authority, on the basis of objective and non-discriminatory criteria, for the purposes of the case concerned, in consultation with flight operations or other experts as necessary, for which an operational risk assessment may be appropriate;
â âmisuse of substancesâ means the use of one or more psychoactive substances by aircrew in a way that, alternatively or jointly:
(a) constitutes a direct hazard to the user or endangers the lives, health or welfare of others;
(b) causes or worsens an occupational, social, mental or physical problem or disorder;
â âpsychoactive substancesâ means alcohol, opioids, cannabinoids, sedatives and hypnotics, cocaine, other psychostimulants, hallucinogens, and volatile solvents, with the exception of caffeine and tobacco;;
â ârefractive errorâ means the deviation from emmetropia measured in dioptres in the most ametropic meridian, measured by standard methods.
Part-MED defines key terms for medical certification of aircrew, including limitations, examinations, assessments, and substance misuse, ensuring clarity for applicants and authorities.
* Summary by Aviation.Bot - Always consult the original document for the most accurate information.
Loading collections...